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Abstract In the bovine, seminal plasma heparin-binding pro-
teins bind to sperm lipids containing the phosphorylcholine group 
and mediate the capacitating effects of heparin-like glycosami-
noglycans during sperm residence in the female genital tract. We 
report the characterization of heparin- and phosphorylcholine-
binding proteins of stallion and boar seminal plasma. Horse 
seminal pjasma proteins HSP-1 and HSP-2, and boar protein 
pBl, belong to the same family as the bull heparin- and 
phosphorylcholine-binding proteins BSP-A1/2, BSP-A3, and 
BSP-30K. We have determined the amino acid sequence and 
posttranslational modifications of boar glycoprotein pBl. It 
contains 105 amino acids arranged into a mosaic structure 
consisting of a N-terminal 18-residue 0-glycosylated polypeptide 
followed by two tandemly organized 40-45-residue fibronectin 
type II domains. pBl displays 60-65% amino acid sequence 
similarity with its equine and bovine homologues. However, in 
their respective seminal plasmas, the BSP and the HSP proteins 
associate into 90-150-kDa oligomeric complexes, whereas pBl 
forms a 35^tO-kDa complex with spermadhesin AQN-1. In 
addition, pBl appears to be identical to the recently described 
leukocyte adhesion regulator of porcine seminal fluid pAIF-1. 
Our results tie in with the hypothesis that homologous proteins 
from different mammalian species may display distinct biological 
activities, which may be related to species-specific aspects of 
sperm physiology. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Seminal plasma, the fluid in which mammalian spermato-
zoa are suspended in semen, is made up by the secretions of 
the male accessory reproductive organs and appears to exert 
important effects on sperm function [1]. Thus, the seminal 
plasma of a variety of mammalian species (including pig, 
cat, rat, goat, horse, ram, bull, rabbit, and human) contains 
decapacitation factors which prevent inappropriate acrosome 
reactions [2]. Inactivation or release of these factors might 
modulate capacitation in vivo during sperm residence in the 
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female's genital tract. On the other hand, bovine seminal plas-
ma contains protein markers associated with Holstein bull 
fertility [3,4]. In addition, bovine seminal plasma heparin-
binding proteins bind to phosphorylcholine-containing lipids 
of cauda epididymal spermatozoa at ejaculation and invoke 
sperm capacitation mediated by heparin-like glycosaminogly-
cans secreted by the epithelium of the female reproductive 
tract, thereby enhancing the fertilizing capacity of spermato-
zoa [5]. Furthermore, seminal plasma carbohydrate- and hep-
arin-binding proteins of the spermadhesin family coat the 
sperm surface of boar and stallion spermatozoa at ejaculation 
and are thought to participate in sperm capacitation and in 
the recognition and initial protein-carbohydrate binding 
mechanism of homologous gametes at fertilization [6,7]. 
Increasing evidence indicates that the concerted action of 
positive and negative regulatory seminal plasma factors may 
modulate the capacitation state and fertilizing capability of 
mammalian spermatozoa in those species investigated so far. 
Heparin binding to acceptor molecules of seminal plasma ori-
gin which coat the sperm surface at ejaculation has been 
documented to play a major role in in vitro bull sperm ca-
pacitation [5,8,9]. However, both the protein composition of 
seminal plasma and the physiological effects of heparin vary 
from species to species [8]. In the horse this effect appears to 
be moderate; and heparin is not necessary for in vitro sperm 
capacitation in the pig [8,9]. The primary structures of the 
major heparin- and phosphorylcholine-binding proteins of bo-
vine seminal plasma (BSP-A1/2, BSP-A3, and BSP-30K) 
([9,10] and references therein) show that these proteins belong 
to the same protein family. Each of these proteins displays a 
mosaic architecture, which consists of N-terminal distinctly O-
glycosylated polypeptide extensions of variable length fol-
lowed by two tandemly arranged, highly conserved fibronectin 
type II domains. On the other hand, the bulk of the boar 
seminal plasma heparin-binding proteins are members of the 
spermadhesin family [11] and do not show phosphorylcholine-
binding activity. 
Phosphorylcholine-binding proteins from the seminal fluid 
of different mammalian species share antigenic determinants 
with bovine BSP-A1/2, BSP-A3, and BSP-30K [12]. Here we 
report the characterization of stallion and boar seminal plas-
ma heparin- and phosphorylcholine-binding proteins. Our re-
sults confirm that the stallion, boar, and bovine phosphoryl-
choline-binding proteins belong to the same protein family. 
However, the porcine protein (pBl) displays biological activ-
ities other than those documented for bovine and equine 
phosphorylcholine- and heparin-binding proteins. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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2. Materials and methods 
2.1. Isolation of phosphorylcholine-binding proteins 
Boar and stallion seminal plasmas were obtained by 15 min centri-
fugation at 1500Xg (room temperature) of freshly ejaculated semen. 
The supernatant was further clarified by centrifugation at 14 000 X g 
for 15 min at room temperature, and 100 ml was applied to a heparin-
Sepharose CL-6B (Pharmacia) column (16x3 cm) equilibrated in 50 
mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, 0.025% (w/v) sodium 
azide, pH 7.4 (TBS). After washing, the column was eluted with the 
same buffer containing 10 mM o-phosphorylcholine (Sigma). Eluted 
proteins were dialyzed extensively against TBS and applied to a 10 X 1 
cm />-aminophenyl phosphorylchohne (Pierce) column equilibrated in 
TBS. The column was washed until the absorbance at 280 nm reached 
baseline, and the bound proteins were eluted with column buffer con-
taining 10 mM phosphorylchohne. 
2.2. Characterization of isolated proteins 
Protein fractions were analyzed by SDS-(15%) polyacrylamide gel 
electrophoresis [13]. Boar seminal plasma proteins were separated by 
reverse-phase HPLÇ on a Lichrospher RP100 C18 (25x0.4 cm, 5 |xm 
particle size, 100 A pore size) (Merck) eluted at 1 ml/min with a 
mixture of 0.1% (v/v) trifluoroacetic acid in water (solution A) and 
acetonitrile (solution B), first isocratically (25% B) for 5 min, followed 
by a gradient of 25-35% B for 10 min, and 35-50% for 60 min. 
Stallion seminal plasma proteins were separated using the same pro-
cedure as for the boar proteins but using the Chromatographie con-
ditions described in [14]. Detection was done at 220 nm, peaks were 
collected manually, and dried using a Speed-Vac (Savant). 
N-terminal amino acid sequence analyses were done with Applied 
Biosystems sequencers 473A and Procise following the manufacturer's 
instructions. 
Molecular masses of reverse-phase HPLC isolates were determined 
by electrospray ionization mass spectrometry using a Sciex API-Ill 
triple quadrupole mass spectrometer. 
Apparent molecular masses of heparin-bound, phosphorylcholine-
eluted protein mixtures were determined by size exclusion chromatog-
raphy using a Superose-12 column and a FPLC system. The column 
was equilibrated in 10 mM MOPS, pH 7.0, with or without 10 mM 
phosphorylchohne. 
Quantification of the protein content in the Chromatographie frac-
tions and amino acid composition of isolated proteins were carried 
out using an Alpha Plus amino acid analyzer (Pharmacia) after sam-
ple hydrolysis with 6 M HC1 for 24 h at 110°C in evacuated and 
sealed ampoules. 
For amino sugar and neutral sugar analyses, the samples were 
hydrolyzed with 4 M HC1 for 4 h or 2 M HC1 for 2 h at 110°C. 
For sialic acid determination, the samples were hydrolyzed with 0.2 M 
trifluoroacetic acid for 1 h at 80°C. After drying the hydrolysates in a 
Speed Vac, the monosaccharides were resolved on a CarboPac PA1 
column (25x0.4 cm) eluting at 1 ml/min isocratically with either 16 
mM NaOH (for amino and neutral sugars) or 20 mM NaOH in 60 
mM sodium acetate (for sialic acid), and analyzed using a Dionex 
DX-300 analyzer equipped with pulsed amperometric detector and 
the AI-450 chromatography software [15]. 
Analytical ultracentrifugation was done in a Beckman XL-A cen-
trifuge with absorption optics. Sedimentation velocity runs were per-
formed in standard double sector cells. Molecular masses were eval-
uated from sedimentation velocity experiments by simultaneous 
determination of the sedimentation and diffusion coefficients from 
the movement and broadening of the sedimenting band according 
to Lamm's equation [16] as described [17]. 
2.3. Peptide mapping 
For peptide mapping, isolated proteins (2-5 mg in 100 mM ammo-
nium bicarbonate, pH 8.3) were digested with trypsin (Sigma) or 
endoproteinase Lys-C (Boehringer Mannheim) at an enzyme:sub-
strate ratio of 1:100 (w/w) for 18 h at 37°C. Proteolytic peptides 
were separated by reverse-phase HPLC on a Lichrospher RP100 
C18 25x0.4 cm column (Merck) (5 urn particle size) eluted at 1 ml/ 
min with a gradient of 0.1% (v/v) trifluoroacetic acid in (solution A) 
water and (solution B) acetonitrile as follows: isocratically with 10% 
solution B for 5 min, followed by 10-35% solution B for 105 min, and 
50-70% solution B for 30 min. Cleavage of proteins (10 mg/ml in 70% 
(v/v) formic acid) at methionine residues was performed with cyano-
gen bromide (100 mg/ml) overnight at room temperature, in the dark, 
and under a nitrogen atmosphere. CNBr-derived fragments were iso-
lated by reverse-phase HPLC as above using the following Chromato-
graphie conditions: isocratically (10% B) for 5 min, followed by 10-
50% B for 80 min, and 50-70% B for 20 min. 
2.4. Titration of thiol groups and location of disulfide bonds 
For quantitation of free cysteine residues and disulfide bonds the 
protein (2 mg/ml in 100 mM Tris-HCl, pH 8.6, 1 mM EDTA, 6 M 
guanidine hydrochloride) was incubated with either 10 mM iodoace-
tamide for 1 h at room temperature, or with 1% (v/v) 2-mercapto-
ethanol for 2 min at 100°C followed by addition of a 2.5 molar excess 
of iodoacetamide over reducing agent for 1 h at room temperature. 
Both samples were dialysed against deionized (MilliQ) water, lyophi-
lized, and subjected to amino acid analysis. For location of cystine 
residues, native pBl was degraded with trypsin and the peptides were 
isolated by reverse-phase HPLC (as above) and characterized by ami-
no acid analysis. 
2.5. Similarity search and prediction of O-glycosylation sites 
Amino acid sequence similarity searches were carried out using the 
program FASTA [18] implemented in the GCG Sequence Analysis 
Software Package and the protein sequences deposited in the data 
bank of the Martinsried Institute for Protein Sequences (MIPS). 
The pBl amino acid sequence was submitted to the NetOGlyc server 
[19] for prediction of O-glycosylation sites [20]. 
3. Results 
3.1. Isolation of stallion and boar phosphorylcholine-binding 
proteins 
For isolation of heparin- and phosphorylcholine-binding 
proteins from the stallion and the boar, the seminal plasmas 
were subjected to affinity chromatography on heparin-Sephar-
ose and bound proteins were eluted with phosphorylchohne. 
This method has been employed for fractionation of bovine 
seminal plasma proteins [21]. In both cases, the stallion and 
boar proteins recovered in the phosphorylchohne eluates were 
resolved into two protein fractions by reverse-phase H P L C 
(Fig. 1). N-terminal sequence determination, peptide map-
ping, and compositional and mass spectrometric analyses 
showed the stallion proteins to be HSP-1 and HSP-2 (peaks 
1 and 2 in Fig. 1A, respectively), which had been previously 
characterized as the major heparin- and gelatin-binding gly-
coproteins of equine seminal plasma [14,22]. Both proteins are 
structurally related and belong to the same protein family as 
the bovine phosphorylcholine-binding proteins B S P - A ^ , 
BSP-A3 , and BSP-30K ([10] and references therein). At posi-
tions 67-69 of HSP-1 we found S W K instead of IQV, as 
previously reported [22]. Sequence analyses of several c D N A 
Fig. 1. Characterization of phosphorylcholine-binding proteins. Reverse-phase HPLC separation of heparin-bound proteins from stallion (A) 
and boar (B) seminal plasma proteins eluted with phosphorylchohne. Inserts, SDS-gel polyacrylamide electrophoretic analysis of protein frac-
tions: (A), sp, total seminal plasma proteins; h, proteins bound to the heparin-Sepharose column eluted with 1 M NaCl; 1 and 2, peaks 1 and 
2 obtained by reverse-phase separation of the subset of heparin-bound proteins eluted with phosphorylchohne. (B) Lanes 1 and 2, peaks 1 and 
2 obtained by reverse-phase separation of the subset of heparin-bound proteins eluted with phosphorylchohne; pc, total proteins eluted from 
the heparin-Sepharose column with phosphorylchohne. In A and B, lane s show molecular mass markers: from top to bottom, phosphorylase 
b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (21 kDa), and lyso-
zyme (14 kDa). 
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Fig. 2. The primary structure of boar pBl. Fragments labeled CNBr and K are peptides obtained by degradation of pyridylethylated pBl with 
cyanogen and endoproteinase Lys-C, respectively. T* denotes tryptic peptides of native pBl; X is an unidentified residue, which correspond to 
an O-glycosylated threonine. 
clones confirmed that HSP-1 actually contains the sequence 
SKW (S. Bellair et a l , unpublished results). 
On the other hand, the N-terminal sequences of pyridyl-
ethylated boar proteins were: DQHLPGRFLXPAITSD-
DKCVFPFIYKGNLYFDCTLHDSTYYWCSVTTYYMKR 
and AQNKGPHKCGGVLRDLSGRISTYEGPKTDCIWTI-
LAKPGS (Fig. IB, peaks 1 and 2, respectively). The N-ter-
minal sequence of peak 1 has been previously reported for a 
minor boar seminal plasma heparin-binding protein termed 
pBl [11] and for a leukocyte adhesion stimulating factor iso-
lated from porcine seminal fluid [23]. The N-terminal sequence 
of peak 2 together with the molecular mass of the protein 
(which was 11 828 ± 1 Da) identified this protein as spermad-
hesin AQN-1 [24]. 
Quantitation of proteins, done by amino acid analysis after 
reverse-phase HPLC separation, showed that in both cases, 
HSP-1 and HSP-2, and pBl and AQN-1 were present in 
roughly equimolar concentrations in the stallion and boar 
heparin-bound, phosphorylcholine-eluted fractions, respec-
tively. 
When subjected to affinity chromatography on phosphoryl-
choline-agarose, HSP-1 and HSP-2 bound to the affinity col-
umn both as a mixture and when HPLC-isolated proteins 
were analyzed. However, when either the pBl/AQN-1 mixture 
or the individual components (separated by reverse-phase 
HPLC) were chromatographed, only pBl bound to the phos-
phorylcholine-agarose column. 
The apparent molecular mass of the HSP-1/HSP-2 mixture, 
determined by size exclusion chromatography after removal of 
phosphorylcholine by extensive dialysis, was 90 kDa. The 
same value has been previously reported for heparin-bound 
HSP-l/HSP-2 mixture eluted with 1 M NaCl [25], However, 
when the 90-kDa HSP-l/HSP-2 complex was chromato-
graphed in buffers containing 20 mM phosphorylcholine, an 
asymmetric double peak with apparent molecular masses of 
38 and 25 kDa was obtained. Reverse-phase HPLC analysis 
revealed that HSP-1 and HSP-2 were quantitatively distrib-
uted in the 38-kDa and 25-kDa FPLC peaks, respectively. 
pBl and AQN-1, in the absence of phosphorylcholine, 
eluted together in a size exclusion Chromatographie fraction 
with apparent molecular mass of 35^40 kDa. Analytical ultra-
centrifugation of pBl and AQN-1, separated by affinity chro-
matography on phosphorylcholine-agarose, showed that these 
proteins sedimented with 1.7 S and 2.9 S, respectively, which 
correspond to a monomeric (14 kDa) and a dimeric (23 kDa) 
protein, respectively. 
3.2. The primary structure of pBl 
The amino acid sequence of boar pBl was established from 
structural information gathered by N-terminal sequencing of 
the intact protein and degradation peptides obtained by deg-
Table 1 
Amino acid of heparin- and phosphorylcholine-binding proteins 
porcine pBl, equine HSP-1, and bovine PDC-109 and BSP-30K 
containing O-glycosylated threonine residues (X) 
Sequence 
G R L F X P A 
D L Q T X G A 
D H S A X V N 
Q L I M X K H 
K H S A X V T 
S T E P X Q D 
G S K P X P S 
D E L P X E T 
P E I Y X T T 
E I Y T X T F 
I Y T T X F L 
F L P R X I Y 
I T S D 
D H S A 
P D Q Q 
S A T V 
P E N K 
P A E L 
G M A D 
Y D L P 
F L P R 
L P R T 
P R T I 
P Q E E 
Score 
0.297 
0.543 
0.557 
0.438 
0.366 
0.149 
0.665 
0.495 
0.350 
0.174 
0.305 
0.665 
Score indicates the prediction strength for threonine: a value above 
the threshold of 0.5 denotes a high probability of becoming O-glyco-
sylated. 
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Fig. 3. Boar, bovine, and stallion seminal plasma phosphorylcholine-binding proteins. Alignment of the amino acid sequence of boar pBl with 
those of bovine BSP-30K, PDC-109 [14] and BSP-A3 [15] and equine HSP-1. The occurrence of unique short repeats (denominated I, II, and 
III) at the N-terminal part of BSP-30K, and the N-terminal extension (labeled A) of HSP-1 are shown. X, O-glycosylated threonine residue. 
Fn Il-a and Fn Il-b, conserved fibronectin type II domains. 
radation of pyridylethylated pBl with cyanogen bromide and 
endoproteinase Lys-C (Fig. 2). The protein has 105 amino 
acids. Quantitation of sulfhydryl groups and disulfide bonds 
clearly showed that the 8 cysteine residues of pBl are engaged 
in four disulfide bridges. They were located by characteriza-
tion of tryptic peptides obtained from digestion of the native 
protein: disulfide bonds between C19-C43, C33-C56, C64-C78, 
and C90-C105 were found in peptides T12*, T6*, Til*, and 
T5*, respectively (Fig. 2). 
Carbohydrate analysis showed that pBl contains N-acetyl-
galactosamine, galactose, and iV-acetylneuraminic acid, indi-
cating that pBl is an O-glycosylated protein. The residue at 
position 10 could not be identified and carbohydrate was 
found only in fragments CNBr-2 and T9* (Fig. 2), strongly 
suggesting that this position carries the single O-glycosylation 
site of pBl. In addition, amino acid analysis of peptide T9* 
demonstrated that the glycosylated residue is threonine. 
The amino acid sequence of pBl displays 60-65% similarity 
with stallion HSP-1 and bovine BSP-A1/2 (also called PDC-
109), BSP-A3, and BSP-30K (Fig. 3). Like the stallion and 
bovine proteins, pBl displays a mosaic structure built by a 
short (18 residues) O-glycosylated N-terminal polypeptide fol-
lowed by a tandem of fibronectin type II (Fn II) modules. The 
amino acid sequence similarity is mainly restricted to the C-
terminal Fn II domains (Fig. 3). 
The fact that bovine PDC-109, stallion HSP-1 and HSP-2, 
and boar pBl are O-glycosylated on threonine residues sug-
gests a common mechanism of glycosylation by a UDP-./V-
acetyl-D-galactosamine : threonine-iV-acetyl-galactosaminyl-
transferase in the three species. In Table 1 the amino acid 
sequences containing O-glycosylated threonine residues of 
the four glycoproteins are compared along with the score 
for threonine glycosylation assign by the NetOGlyc server 
[19]. The absence of structural characteristics common to 
the 12 amino acid sequences (Table 1) and the different scores 
obtained indicate that the galactosyltransferase may display 
few amino acid sequence requirements and may glycosylate 
suitably exposed threonine residues. 
4. Discussion 
Seminal plasma phosphorylcholine-binding proteins, which 
share antigenic determinants with bovine BSP-A^, BSP-A3, 
and BSP-30K have been identified in a number of species 
including bull, human, boar, hamster, mouse, and rat [12]. 
Here we have isolated and characterized the heparin- and 
phosphorylcholine-binding proteins of stallion and boar semi-
nal plasmas (HSP-1 and HSP-2, and pBl, respectively). These 
proteins are structurally related and belong to the same pro-
tein family as the bovine BSP proteins. 
Our results indicate that stallion seminal plasma HSP-1 and 
HSP-2 associate into a 90-kDa hetero-oligomer with both 
subunits displaying heparin- and phosphorylcholine-binding 
activity. This oligomer is dissociated by phosphorylcholine 
into HSP-1 and HSP-2 monomers (apparent molecular mass 
by SDS-PAGE 28 and 22 kDa, respectively). From these data 
we conclude that the 90-kDa HSP-1/HSP-2 oligomer corre-
sponds most probably to a tetrameric assembly of HSP-1 and 
HSP-2. On the other hand, boar seminal plasma pBl and 
AQN-1 form a stoichiometric 35^10-kDa complex, which pos-
sesses phosphorylcholine-binding activity associated with the 
pBl subunit. From its apparent molecular mass, we propose 
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that the pBl/AQN-1 complex might have the composition 
(pBl)2(AQN-l)2. This oligomer is also dissociated through 
interaction with phosphorylcholine into monomeric pBl and 
AQN-1 dimers. 
In bull seminal plasma, the major phosphorylcholine- and 
heparin-binding protein PDC-109 exists as a 90-120-kDa 
homo-oligomer [26], which can be dissociated to homodimer 
by interaction with phosphorylcholine (data not shown). 
Hence, it seems that the phosphorylcholine- and heparin-bind-
ing proteins from bull, stallion, and boar seminal plasmas 
share the property of forming phosphorylcholine-dependent 
oligomeric structures. 
Here, and in previous works [10,22,27,28], we have shown 
that the major bovine, stallion, and boar seminal plasma hep-
arin- and phosphorylcholine-binding proteins display a mod-
ular architecture composed of two tandemly arranged and 
largely conserved C-terminal fibronectin type II domains 
and unique N-terminal extensions of variable length that are 
O-glycosylated to different extents. Although it remains to be 
established whether the variable N-terminal extensions or the 
conserved Fn II domains are responsible for the oligomeriza-
tion activity, the observations that the type and extent of 
glycosylation indirectly affects the heparin-binding capability 
of stallion seminal plasma HSP-1 and HSP-2 proteins through 
modulation of their aggregation state [22,25] points to the 
variable N-terminal polypeptides as the oligomerization-deter-
mining domain. 
The bovine proteins have been implicated in sperm capaci-
tation modulated by heparin [5,29,30], suggesting that the 
stallion and boar homologues could play a similar physiolog-
ical role. The effect of heparin in these mammalian species 
differs, however, from that observed in the bovine. Thus, hep-
arin-like glycosaminoglycans (GAGs) of follicular fluid exert a 
moderate effect on stallion sperm capacitation [31] and act as 
a acrosome-reaction-inducing factor in the pig [32]. Indeed 
various authors have posed the question of whether GAG 
action mechanisms in prefertilization processes might be spe-
cies-specific [33]. We hypothesize that formation of different 
oligomers may determine the distinct biological effects exerted 
by seminal plasma heparin-binding proteins in bovine, equine, 
and porcine species. 
Finally, Hadjisavas et al. [23] have characterized a leuko-
cyte adhesion-inducing 15-kDa protein (pAIF-I) from porcine 
seminal vesicle fluid which has the same 32 N-terminal amino 
acids as pBl. pAIF-I is proposed to mediate activation of 
leukocytes at the site of inflammation which occurs occasion-
ally upon mating. This suggests that seminal plasma and 
sperm-associated pBl molecules may play diverse biological 
roles. Whether the same holds for homologous proteins from 
other mammalian species deserves further investigation. 
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